The Voice of Epidemiology

    
    


    Web EpiMonitor

► Home ► About ► News ► Jobs ► Events ► Resources ► Contact

Keynotes

Humor Quotes Wit & Wisdom EpiSource Miscellany Editor's Tips Triumphs Links Archives
 


Epi Wit & Wisdom Resources

The Private Practice of Epidemiology

Robert W. Morgan, MD

This is the second in a series of commentaries by members of the Epi Monitor Advisory Board. We are interested in publishing the opinions of epidemiologists on a variety of issues of current interest to the profession. All readers are invited to submit comments which they believe may be of interest to the general epidemiology community.

I am frequently asked two questions concerning the private practice of epidemiology. The first is “Uh, how do you get your...uh, customers?” followed by, “Is there more work around?” Since our company specializes in occupational and environmental epidemiology contract research, usually for industry, the questions are appropriate. So far, I have resisted the urge to run advertisements in the Epi Monitor or AJE, exhorting all to “Make Money at Home, Send $$$ for Valuable Kit to Establish Contacts and Attract Projects.” And I have opted not to turn the repetitive questions into a syndicated “Do-It-Yourself Entrepeneurial Column for Ambitious Epidemiologists.”

Market For Epidemiologists

We have proven, though, that there is a commercial market for epidemiologists’ services. That market we share with numerous universities and a few other companies, some of which rely on part-time academics. We suspect that the market may have peaked and is now in a mild decline, with relatively few new and large projects in the planning stage. We also see that competitors are increasing in number, especially as Federal grants and contracts become scarcer. It may be unfortunate that if the best investigators get funded by Government, the less competent will look to private industry--our main client source--for money and support. I say unfortunate because occupational and environmental epidemiology poses some incredibly difficult problems that deserve the skill and ingenuity of the level possessed by the most successful researchers, academic or otherwise.

Advantages

As private practitioners, we enjoy certain commercial advantages over academic competitors. For one thing, we are available full-time and not tied down by teaching and committee schedules. We suspect that we offer lower prices overall because of an efficient organization, although some of our individual hourly rates may appear higher. We track projects by the quarter-hour so our invoices reflect exact labor; we do not estimate professional effort in 5% multiples. Finally, our time sheets can be audited so that clients get the persons they pay for and never junior staff or students.

Is my practice fun? Certainly. How else in the course of a year could I deal with sperm counts in Hawaii, occupational asthma in New Jersey, abortions in Louisiana and leukemia in Texas? With congenial colleagues (we have four partners) for daily consultation, a capable staff (about 25 persons) and interesting scientific problems, it is a great job.

Disadvantages

What is the “bad news?” First, since we have neither endowment nor tenure, our financial security is not assured. Second, most of our research arises out of controversy (other people’s fires) rather than from the generation of sound biologic hypotheses. Finally, our clients expect quick response, which might include flying the same day. They also expect a project to finish on time and on budget. As a minor annoyance, we must keep close track of our time with detailed time sheets.

On rare occasions, a colleague will question our credibility because we “take money from industry.” Is there somehow the illusion that a university Contracts Office makes cleaner the dirty money of industry? My somewhat sour question illustrates a certain paranoia, since, of course, both academic and free-enterprise epidemiologists must maintain objectivity and never compromise scientific integrity for mere money. If anything, the epidemiologic entrepreneur must bend over backward to ensure quality and objectivity that will withstand scrutiny, since the accusation of “industry’s whore” can be made so offhandedly.

Publishing? Although this is not our primary goal, we usually find no problem in publishing. Many clients ask us to publish, even before they know the results. Others wait to see results, but they rarely attempt to prohibit or delay making public an important finding. We encourage publication, because it ensures our clients of some peer review. It is also our best advertising medium.

Want to start? Your survival kit should include the following instructions:

1) How to assemble a multi-disciplinary team that will attract business

2) How to become known to Fortune 500 companies

3) How to examine a problem; design a study; and write a proposal in 10 days or less

4) How to deliver bad news

5) How to explain lack of power in a negative study

6) How to advise against doing a study that will make you money

7) How to maintain your staff, sanity and composure when a client delays paying an invoice for 18 months with repeated variations on the theme that, “The check is in the mail.”

After the kit, all you need is capital, equanimity, courage, perseverance and optimism. In keeping with the history of all pure and applied sciences, however, one of the most important ingredients for success has been LUCK!

Dr. Morgan, a member of the Epi Monitor Advisory Board, is with Environmental Health Associates Inc, 2150 Shattuck Ave, Berkeley, CA 94704.

Published June 1982 

 

 
      ©  2011 The Epidemiology Monitor

Privacy  Terms of Use  |  Sitemap

Digital Smart Tools, LLC